KR920019364A - 약학적 화합물 - Google Patents

약학적 화합물 Download PDF

Info

Publication number
KR920019364A
KR920019364A KR1019920007116A KR920007116A KR920019364A KR 920019364 A KR920019364 A KR 920019364A KR 1019920007116 A KR1019920007116 A KR 1019920007116A KR 920007116 A KR920007116 A KR 920007116A KR 920019364 A KR920019364 A KR 920019364A
Authority
KR
South Korea
Prior art keywords
dirithromycin
pharmaceutical compound
solvate
propanol
slurrying
Prior art date
Application number
KR1019920007116A
Other languages
English (en)
Other versions
KR100194307B1 (ko
Inventor
마이클 그린 제임스
마리 핸킨스 홀리
알란 스테펜슨 그레고리
데일 위쓰 데이비드
Original Assignee
일라이 릴리 앤드 캄파니
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 일라이 릴리 앤드 캄파니 filed Critical 일라이 릴리 앤드 캄파니
Publication of KR920019364A publication Critical patent/KR920019364A/ko
Application granted granted Critical
Publication of KR100194307B1 publication Critical patent/KR100194307B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Formation And Processing Of Food Products (AREA)

Abstract

내용 없음

Description

약학적 화합물
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (3)

  1. 디리트로마이신의 아세톤, 1-부탄올, 1-프로판올 또는 2-프로판올 용매화물.
  2. 본질적으로 하기 X-선 분말 회절 패턴을 갖는 정재된 형태 Ⅱ디리트로마이신.
    여기서, d는 결정면간 거리를 나타낸다.
  3. 제1항에 청구된 바와 같은 용매화물을 40% 내지 100%의 물을 포함하는 용매중에서 슬러리화시킴을 포함하는, 제2항에 청구된 바와 같은 형태 Ⅱ 디리트로마이신의 제조방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019920007116A 1991-04-29 1992-04-27 약학적화합물 KR100194307B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US69284291A 1991-04-29 1991-04-29
US07/692,842 1991-04-29
US7/692,842 1991-04-29

Publications (2)

Publication Number Publication Date
KR920019364A true KR920019364A (ko) 1992-11-19
KR100194307B1 KR100194307B1 (ko) 1999-06-15

Family

ID=24782254

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1019920007117A KR100193742B1 (ko) 1991-04-29 1992-04-27 디리트로마이신을 함유하는 약학 제형
KR1019920007116A KR100194307B1 (ko) 1991-04-29 1992-04-27 약학적화합물

Family Applications Before (1)

Application Number Title Priority Date Filing Date
KR1019920007117A KR100193742B1 (ko) 1991-04-29 1992-04-27 디리트로마이신을 함유하는 약학 제형

Country Status (27)

Country Link
EP (2) EP0511799B1 (ko)
JP (2) JP3135672B2 (ko)
KR (2) KR100193742B1 (ko)
CN (2) CN1069197C (ko)
AT (2) ATE138924T1 (ko)
AU (2) AU655978B2 (ko)
BR (2) BR9201541A (ko)
CA (2) CA2067275C (ko)
CY (2) CY1946A (ko)
CZ (2) CZ282218B6 (ko)
DE (2) DE69214710T2 (ko)
DK (2) DK0511799T3 (ko)
ES (2) ES2088098T3 (ko)
FI (2) FI921876A (ko)
GR (2) GR3020439T3 (ko)
HK (2) HK153696A (ko)
HU (2) HU213613B (ko)
IE (2) IE74885B1 (ko)
IL (2) IL101705A (ko)
MX (2) MX9201946A (ko)
MY (2) MY114226A (ko)
NO (2) NO180450C (ko)
NZ (2) NZ242505A (ko)
RU (2) RU2070203C1 (ko)
TW (2) TW216399B (ko)
YU (2) YU44392A (ko)
ZA (2) ZA922777B (ko)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW271400B (ko) * 1992-07-30 1996-03-01 Pfizer
CR5278A (es) * 1995-03-24 1996-07-04 Lilly Co Eli Formulacion oral de 2-metil-tieno-benzodiacepina
ES2173057T3 (es) * 1996-07-29 2004-11-16 Abbott Laboratories Preparacion de la forma ii cristalina de claritromicina.
ID21762A (id) * 1996-09-24 1999-07-22 Lilly Co Eli Formulasi partikel bersaput
US6390690B1 (en) 2000-05-17 2002-05-21 3M Innovative Properties Company Fiber optic connector for coupling devices on intersecting planes
CA2670482C (en) * 2006-12-05 2011-10-11 Pfizer Inc. Motilide polymorphs
CN102145008B (zh) * 2010-12-29 2013-06-05 辰欣药业股份有限公司 一种地红霉素药物组合物及其制备方法
CN107151261B (zh) * 2017-06-09 2020-06-12 广州大光制药有限公司 一种地红霉素化合物的晶型及其结晶制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT342770B (de) * 1975-04-07 1978-04-25 Thomae Gmbh Dr K Verfahren zur herstellung neuer erythromycinderivate
DE2515075C2 (de) * 1975-04-07 1985-10-24 Dr. Karl Thomae Gmbh, 7950 Biberach Erythromycinderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
EP0184921A3 (en) * 1984-12-08 1986-10-29 Beecham Group Plc Erythromycin derivatives
DE3524572A1 (de) * 1985-07-10 1987-01-15 Thomae Gmbh Dr K Feste arzneimittelformen zur peroralen anwendung enthaltend 9-deoxo-11-deoxy-9,11-(imino(2-(2-methoxyethoxy)ethyliden)-oxy)-(9s)-erythromycin und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
MY114226A (en) 2002-09-30
JPH05117289A (ja) 1993-05-14
AU1525792A (en) 1992-11-05
FI101795B1 (fi) 1998-08-31
EP0511800A1 (en) 1992-11-04
CY1946A (en) 1992-04-27
NO921616L (no) 1992-10-30
AU655978B2 (en) 1995-01-19
KR100193742B1 (ko) 1999-06-15
CA2067275A1 (en) 1992-10-30
RU2070203C1 (ru) 1996-12-10
NO921616D0 (no) 1992-04-27
YU44492A (sh) 1994-06-24
ZA922776B (en) 1993-10-15
HUT63956A (en) 1993-11-29
AU1525592A (en) 1992-11-05
IE76296B1 (en) 1997-10-08
MY109498A (en) 1997-02-28
IL101704A (en) 1998-02-22
YU44392A (sh) 1994-12-28
GR3021706T3 (en) 1997-02-28
DE69214710T2 (de) 1997-03-13
CS127792A3 (en) 1992-11-18
FI921876A0 (fi) 1992-04-27
ZA922777B (en) 1993-10-15
GR3020439T3 (en) 1996-10-31
CZ282218B6 (cs) 1997-06-11
CN1066186A (zh) 1992-11-18
KR920019365A (ko) 1992-11-19
HU213613B (en) 1997-08-28
NO921617L (no) 1992-10-30
HK215096A (en) 1996-12-13
BR9201541A (pt) 1992-12-01
CA2067274A1 (en) 1992-10-30
NZ242506A (en) 1993-09-27
CN1066270A (zh) 1992-11-18
CZ282021B6 (cs) 1997-04-16
MX9201946A (es) 1992-11-01
TW315371B (ko) 1997-09-11
FI921877A0 (fi) 1992-04-27
IE74885B1 (en) 1997-08-13
HU9201398D0 (en) 1992-07-28
JPH05117154A (ja) 1993-05-14
FI921877A (fi) 1992-10-30
CY1975A (en) 1997-09-05
IL101705A (en) 1996-01-31
NZ242505A (en) 1993-06-25
AU646734B2 (en) 1994-03-03
ES2093779T3 (es) 1997-01-01
HK153696A (en) 1996-08-16
CN1069197C (zh) 2001-08-08
IL101704A0 (en) 1992-12-30
CA2067275C (en) 2002-11-26
KR100194307B1 (ko) 1999-06-15
TW216399B (ko) 1993-11-21
CN1030611C (zh) 1996-01-03
CS127692A3 (en) 1992-11-18
CA2067274C (en) 2002-10-15
DE69214710D1 (de) 1996-11-28
MX9201944A (es) 1992-11-01
DE69211220D1 (de) 1996-07-11
DE69211220T2 (de) 1996-11-07
NO180450B (no) 1997-01-13
HU215917B (hu) 1999-03-29
IL101705A0 (en) 1992-12-30
DK0511800T3 (da) 1997-04-21
NO180450C (no) 1997-04-23
HUT62595A (en) 1993-05-28
ATE138924T1 (de) 1996-06-15
EP0511799A1 (en) 1992-11-04
FI101795B (fi) 1998-08-31
NO179504C (no) 1996-10-23
EP0511800B1 (en) 1996-10-23
ATE144425T1 (de) 1996-11-15
IE921346A1 (en) 1992-11-04
EP0511799B1 (en) 1996-06-05
NO921617D0 (no) 1992-04-27
JP3333545B2 (ja) 2002-10-15
NO179504B (no) 1996-07-15
FI921876A (fi) 1992-10-30
JP3135672B2 (ja) 2001-02-19
RU2045953C1 (ru) 1995-10-20
BR9201540A (pt) 1992-12-01
IE921345A1 (en) 1992-11-04
DK0511799T3 (da) 1996-06-24
HU9203168D0 (en) 1992-12-28
ES2088098T3 (es) 1996-08-01

Similar Documents

Publication Publication Date Title
CA2043976A1 (en) Substituted phthalides and heterocyclic phthalides
LU88712I2 (fr) TAXOTERE-Décotaxel
IL90912A0 (en) Condensed heterocyclic compounds,their manufacture and pharmaceutical compositions containing them
SE8200171L (sv) 3-aminopropoxiaryl-derivat, framstellning derav och lekemedel innehallande dessa
CS656082A2 (en) Zpusob vyroby derivatu s adenosylmethioninu
ATE137402T1 (de) Retinoid enthaltende dermatologische und/oder kosmetische zusammensetzungen
IT8983386A0 (it) Procedimento per la preservazione di materiali cellulosici stampati.
KR920019364A (ko) 약학적 화합물
KR900000335A (ko) 히드록시알킬시스테인 유도체 및 이를 함유하는 거담제
KR890003752A (ko) 2-피리미디닐-피페라딘 유도체의 용도
KR870005968A (ko) 아미드 유도체 및 이를 함유하는 외용약제
JPS57179158A (en) Oxindole derivative
DE69012619D1 (de) Bis(1-Hydrocarbyloxy-2,2,6,6-tetramethylpiperidin-4-yl)-amin-derivate und stabilisierte Zusammensetzungen.
GR3004165T3 (ko)
ES2039211T3 (es) Nuevos n-glicosilamidoderivados, procedimientos para su obtencion y su empleo como medicamentos.
IE820199L (en) Dibenzofuran derivatives
KR910000165A (ko) 비경구 투여용 fr 115224 물질의 제제
KR830004845A (ko) 약제학적 제제
KR880004751A (ko) 닭용 사료(鷄用飼料)
ES485992A1 (es) Procedimiento para la obtencion de un fungicida a base de carboximidas y derivados sulfamidicos
AU535125B2 (en) Cyclophosphathiazene derivatives
KR890014101A (ko) 동맥경화증 치료제
KR840004758A (ko) 새로운 세펨화합물의 제조방법
KR930002245A (ko) 중금속 침전제로 사용되는 1. 3-Dimercapto-2-propanol
ATE92064T1 (de) Neue 1,3,4,-thiadiazolderivate und antigeschwulstmittel, die diese enthalten.

Legal Events

Date Code Title Description
A201 Request for examination
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
G170 Re-publication after modification of scope of protection [patent]
FPAY Annual fee payment

Payment date: 20070108

Year of fee payment: 9

LAPS Lapse due to unpaid annual fee